drugset / Trial / NCT00009958
Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Phase I trial to compare the effectiveness of vaccine therapy with or without sargramostim in treating patients who have solid tumors. Vaccines may make the body build an immune response to kill tumor cells. Combining colony-stimulating factors such as sargramostim with vaccines may kill more tumor cells.
Timeline
- Start
- 2000-11
- Primary completion
- 2010-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rF-CEA(6D)-TRICOM | Vaccine | — | Subcutaneous |
| Subject | recombinant vaccinia-CEA(6D)-TRICOM vaccine | Vaccine | — | Other |
| Subject | sargramostim | Protein / enzyme biologic | — | Subcutaneous |